Levodopa reverses cytokine-induced reductions in striatal dopamine release.
about
Brain Structures Implicated in Inflammation-Associated Depression.Systemic inflammation enhances stimulant-induced striatal dopamine elevation.Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic AcidInflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depressionInterferon-α acutely impairs whole-brain functional connectivity network architecture - A preliminary studyCandidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.Ventricular fibrillation cardiac arrest produces a chronic striatal hyperdopaminergic state that is worsened by methylphenidate treatment.Biological Aging and the Future of Geriatric Psychiatry.Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.Overweight and Cognitive Performance: High Body Mass Index Is Associated with Impairment in Reactive Control during Task Switching.Imaging the role of inflammation in mood and anxiety-related disorders.Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Anhedonia in depression: biological mechanisms and computational models.The relationship between interleukin-6 and functional connectivity in methamphetamine users.
P2860
Q31106139-9CDCD688-382B-48EF-8B95-08237985A0DEQ33601884-F76088AA-E36C-4362-8BFF-0044CA21B676Q36260394-2EF4CB84-6350-477D-B675-948CDD611A1AQ36442352-83841C68-73C8-4FFE-BA5A-9E4F0C27AC5AQ36889327-54FF3320-E7C4-4F23-AEB9-F6F1AAA3B252Q37357695-DD71F330-D317-433A-8B04-CC24457D6FCDQ38556918-372C067C-A4C9-488D-9924-3B32F7F713E2Q38690582-4321F3AB-669E-4ED8-A81D-5D4553196E99Q38780593-8624EF57-F554-4D97-AECC-D6D32EE042BCQ38828405-FCE159AB-2CF9-4ADC-818C-A677C36B66F1Q38844378-F6856E2B-3F3B-4B36-B087-812B04B328DCQ38915253-CD322B69-8CF4-42E8-B8ED-35AF65F8B400Q39867864-7EDF2E49-528D-4AA5-868B-1630E121FF5CQ45893599-328E12A0-B1B8-4834-A3F0-89CD0E353BF1Q47305318-23BD1F91-8202-44C9-91CD-76D11F7F6BF2Q47318811-A47853F6-3878-43B8-A243-899CDB432CF0Q47586487-5B3236E7-6A36-4614-98A7-3554679A7881Q50420903-A5B60A98-63E7-4880-97F2-7BAD4592A48CQ52318363-F548F12F-B812-437E-8952-F251D31C793C
P2860
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@ast
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@en
type
label
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@ast
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@en
prefLabel
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@ast
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@en
P2093
P2860
P356
P1476
Levodopa reverses cytokine-induced reductions in striatal dopamine release.
@en
P2093
Andrew H Miller
Carla R Hernandez
Jennifer C Felger
P2860
P356
10.1093/IJNP/PYU084
P577
2015-01-31T00:00:00Z